Andrew F Berdel
7PUBLICATIONS
40CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|May 06, 2025
Photodynamic ROS inducers delivered via electrostatic antibody targeted (ELART) nanocarriers incorporate into tumour cells and inhibit colony growth.Andreas Faust, Andrew F Berdel, Evelyn Bruns
|Jan 15, 2025
Common hereditary variants of the APOE gene and posttransplant outcome in acute myeloid leukemia.Julian Ronnacker, Michael Grau, Maximilian Klasmeier
|Apr 25, 2022
Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse.Andrew F Berdel, Leo Ruhnke, Linus Angenendt
|Dec 10, 2021
Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13-Targeted Tissue Factor tTF-NGR in Advanced Malignant Disease.Mirjam Gerwing, Tobias Krähling, Christoph Schliemann
|Jul 02, 2021
Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction.Andrew F Berdel, Christian Schwöppe, Caroline Brand
|Jun 11, 2020
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study.Christoph Schliemann, Mirjam Gerwing, Hauke Heinzow
Pageof 2
Frequent Collaborators
2 joint publications
Hauke Heinzow
2 joint publications
Wolfgang E Berdel
2 joint publications
Moritz Wildgruber
2 joint publications
Linus Angenendt
2 joint publications
Lina Kolloch
2 joint publications
Julian Ronnacker
2 joint publications
Torsten Kessler
2 joint publications
Matthias Stelljes
2 joint publications
Martin Bornhäuser
2 joint publications
Christoph Röllig
